|
|
|
Volumn 24, Issue 6, 2011, Pages 356-357
|
|
Metastatic pancreatic cancer: Another option?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERLOTINIB;
FLUOROURACIL;
FOLINIC ACID;
GEMCITABINE;
IRINOTECAN;
OXALIPLATIN;
ALOPECIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER CYTODIAGNOSIS;
CANCER GROWTH;
CANCER LOCALIZATION;
CANCER SURVIVAL;
CHOLANGITIS;
CLINICAL EFFECTIVENESS;
CONTINUOUS INFUSION;
DIARRHEA;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEBRILE NEUTROPENIA;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
LETTER;
METASTASIS;
MONOTHERAPY;
NEUTROPENIA;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PANCREAS ADENOCARCINOMA;
PANCREAS CANCER;
PROGRESSION FREE SURVIVAL;
QUALITY OF LIFE;
SENSORY NEUROPATHY;
SURVIVAL RATE;
THROMBOCYTOPENIA;
|
|
EID: 84859139918
PISSN: 0970258X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (1)
|
|
References (0)
|
